Press release
Infectious Diseases Treatment Market is expected to Hit US$ 264.75 Billion by 2033 | Major Companies - Pfizer Inc., AbbVie, Gilead Sciences, Inc., Merck & Co., Inc.
Infectious Diseases Treatment Market
The Global Infectious Diseases Treatment Market size reached US$ 189.09 Billion in 2024 from US$ 182.65 Billion in 2023 and is expected to reach US$ 264.75 Billion by 2033, growing at a CAGR of 3.9% during the forecast period 2025-2033.
DataM Intelligence has published a new research report on "Infectious Diseases Treatment Market Size 2026". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/infectious-diseases-treatment-market?sz
The Infectious Diseases Treatment Market refers to the global healthcare sector focused on the development, production, and distribution of therapies used to prevent, manage, and cure infections caused by bacteria, viruses, fungi, and parasites. It includes antibiotics, antivirals, antifungals, vaccines, and supportive therapies designed to control disease transmission and improve patient outcomes. Market growth is driven by rising infection rates, emerging pathogens, antimicrobial resistance concerns, technological advancements, and increased investments in research, diagnostics, and healthcare infrastructure worldwide.
Recent Key Developments of United States:
✅ February 2026: NIH-funded research led to breakthroughs in immunotherapy combinations for fungal infections in immunocompromised patients.
✅ January 2026: CDC partnered with biotech startups to accelerate deployment of rapid point-of-care diagnostics for viral hemorrhagic fevers.
✅ December 2025: Major biopharma firms announced expanded Phase III trials for a next-gen antiviral targeting emerging influenza variants prevalent in the US.
✅ November 2025: FDA approved a novel mRNA-based therapeutic for multi-drug resistant bacterial infections, enhancing treatment options for hospital-acquired pneumonia.
Recent Key Developments of Japan:
✅ February 2026: Biopharma companies expanded plasma fractionation capacity to meet immunoglobulin demand from aging population infections.
✅ January 2026: Regulatory authorities streamlined pathways for plasma-derived therapies addressing autoimmune-linked infectious disorders.
✅ December 2025: Leading firms integrated AI-driven platforms for faster drug discovery against seasonal influenza strains.
✅ November 2025: PMDA fast-tracked approval for advanced hepatitis C direct-acting antivirals with improved cure rates for diverse genotypes.
List of the Key Players in the Infectious Diseases Treatment Market:
Pfizer Inc.
AbbVie
Gilead Sciences, Inc.
Merck & Co., Inc.
Sandoz Group AG
B. Braun SE
Bayer AG
AstraZeneca
Novartis AG
Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/infectious-diseases-treatment-market?sz
This Report Covers:
✔ Go-to-market Strategy.
✔ Neutral perspective on the market performance.
✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
✔Customized regional/country reports as per request and country level analysis.
✔ Potential & niche segments and regions exhibiting promising growth covered.
✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Segments Covered in the Infectious Diseases Treatment Market:
By Infection Type: Viral Infections, Bacterial Infections, Fungal Infections, and Parasitic Infections.
By Drug Class: Antibacterials, Antivirals, Antifungals, Antiparasitic Drugs, and Others.
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies.
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=infectious-diseases-treatment-market
Chapter Outline:
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: key insights, key emerging trends, etc.
Chapter 3: Manufacturers competitive analysis, detailed analysis of Infectious Diseases Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 5 & 6: Revenue of Infectious Diseases Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: The main points and conclusions of the report.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
People Also Ask:
◆ How big is the Infectious Diseases Treatment Market in 2026?
◆ What is the projected growth rate of the Infectious Diseases Treatment Market through 2034?
◆ Who are the key players in the Infectious Diseases Treatment Market?
◆ Which region is expected to dominate the industry during the forecast period?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Infectious Diseases Treatment Market is expected to Hit US$ 264.75 Billion by 2033 | Major Companies - Pfizer Inc., AbbVie, Gilead Sciences, Inc., Merck & Co., Inc. here
News-ID: 4405564 • Views: …
More Releases from DataM Intelligence 4Market Research
Ophthalmology Drugs Market is expected to reach US$ 73.97 Billion by 2033 | Majo …
Market Size and Growth:
The Global Ophthalmology Drugs Market size reached US$ 42.30 Billion with a rise of US$ 44.58 Billion in 2024 and is expected to reach US$ 73.97 Billion by 2033, growing at a CAGR of 5.8% during the forecast period 2025-2033.
DataM Intelligence has published a new research report on "Ophthalmology Drugs Market Size 2026". The report explores comprehensive and insightful Information about various key factors like Regional Growth,…
Neurotherapeutics Market is expected to Hit US$ 11.10 Billion by 2033 | Major Co …
Market Size and Growth:
The Global Neurotherapeutics Market size reached US$ 7.28 Billion in 2024 from US$ 6.97 Billion in 2023 and is expected to reach US$ 11.10 Billion by 2033, growing at a CAGR of 4.9%during the forecast period 2025-2033.
DataM Intelligence has published a new research report on "Neurotherapeutics Market Size 2026". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue…
United Kingdom Brain Supplements Market is expected to Hit US$ 2.87 billion by 2 …
Market Size and Growth:
The UK Brain Supplements Market size reached US$ 0.96 billion in 2024 and is expected to reach US$ 2.87 billion by 2032, growing with a CAGR of 14.66% during the forecast period 2025-2032.
DataM Intelligence has published a new research report on "UK Brain Supplements Market Size 2026". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of…
Internet of Things (IoT) in Agriculture Market is expected to hit US$ 83.26 bill …
Market Size and Growth:
The Global Internet of Things (IoT) in Agriculture Market size reached US$ 31.10 billion in 2023 and is expected to reach US$ 83.26 billion by 2031, growing with a CAGR of 13.1% during the forecast period 2024-2031.
DataM Intelligence has published a new research report on "Internet of Things (IoT) in Agriculture Market Size 2026". The report explores comprehensive and insightful Information about various key factors like Regional…
More Releases for Infectious
Infectious Disease Therapeutics Market - Infectious Disease Solutions: Revolutio …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Infectious Disease Therapeutics Market.
Infectious Disease Therapeutics Market: https://www.growthplusreports.com/report/infectious-disease-therapeutics-market/9210
The Infectious Disease Therapeutics Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the…
Infectious Disease Diagnostics Market Owing to the Increasing Prevalence of Infe …
According to Precision Business Insights (PBI) latest report, the infectious disease diagnostics market is expected to be worth USD 34,599.0 million in 2022, growing at a 6.4% CAGR from 2022 to 2028. Global Infectious Disease Diagnostics Market By Product (Reagents, Kits, and Consumables, Instruments and Software & Services), By Type of Testing (Laboratory Testing and POC Testing), By Technology (Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarrays…
Increasing Prevalence of Infectious Diseases to Augment the Point-of-Care (POC) …
Point-of-care (POC) diagnosis includes sample testing to facilitate rapid diagnosis and decide on treatment planning accordingly. Infectious diseases often need to be diagnosed early, as they can be fatal against the immune system. POC infectious disease diagnostics allows early detection of diseases and can impact the medical outcome of treatment of the disease.
Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/63
The U.S. FDA (United States Food and Drug Administration) is…
Infectious Disease Diagnostics Market Entry Strategies, Countermeasures, Economi …
Market Expertz has published its latest research study titled 'Global Infectious Disease Diagnostics Market Report Forecast to 2027' gives a detailed assessment of the industry to offer vital information by evaluating the prevalent trends observed in the sector. The report includes valuable market insights provided by the industry experts by way of surveys and interviews as part of primary research. The authors of the study also undertake secondary research, which…
Infectious Disease Diagnostics Market
According to Stratistics MRC, the Global Infectious Disease Diagnostics Market is accounted for $14.82 billion in 2017 and is expected to reach $25.90 billion by 2026 growing at a CAGR of 6.4% during the forecast period. Some of the key factors influencing the market are increasing prevalence of infectious diseases, growing R& D activities coupled with the development of novel technologies and rising new diagnostic tests for the control of…
Infectious Disease Diagnostic Market
Infectious disease diagnostics involves identifying the presence of foreign antigen/organism using diagnostic tools such as kits. Most of the standard diagnostic test kits currently available are for bacterial infections and sexually transmitted diseases. However, in future these diagnostic tests are expected to be replaced by molecular techniques.
The global infectious disease diagnostic market is expected to witness significant growth during the forecast period due to increasing prevalence of infectious diseases, increased…
